Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Public Health Informatics | 1 | 2017 | 155 | 0.58 | Why? |
| Population Surveillance | 3 | 2017 | 4967 | 0.46 | Why? |
| Disease Notification | 1 | 2017 | 639 | 0.43 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.24 | Why? |
| Disease Outbreaks | 5 | 2020 | 27595 | 0.24 | Why? |
| Judaism | 1 | 2020 | 45 | 0.20 | Why? |
| Methanobrevibacter | 1 | 2018 | 15 | 0.19 | Why? |
| Enterocolitis, Pseudomembranous | 1 | 2018 | 93 | 0.18 | Why? |
| Microbiota | 2 | 2018 | 1240 | 0.18 | Why? |
| Statistics as Topic | 2 | 2017 | 370 | 0.18 | Why? |
| Bacterial Typing Techniques | 1 | 2018 | 273 | 0.16 | Why? |
| France | 10 | 2021 | 12074 | 0.15 | Why? |
| Global Burden of Disease | 1 | 2019 | 531 | 0.14 | Why? |
| Tobacco Smoking | 1 | 2018 | 349 | 0.13 | Why? |
| Health Status Indicators | 1 | 2017 | 341 | 0.13 | Why? |
| Bacterial Infections | 2 | 2017 | 2229 | 0.13 | Why? |
| Probability | 1 | 2017 | 923 | 0.13 | Why? |
| Mouth | 1 | 2018 | 622 | 0.13 | Why? |
| Endocarditis | 1 | 2017 | 368 | 0.12 | Why? |
| Mass Spectrometry | 1 | 2018 | 1165 | 0.12 | Why? |
| Drug Resistance, Viral | 1 | 2018 | 1083 | 0.11 | Why? |
| Clostridium Infections | 1 | 2018 | 595 | 0.11 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2020 | 1234 | 0.10 | Why? |
| Genotype | 2 | 2021 | 4697 | 0.10 | Why? |
| Ships | 1 | 2017 | 1046 | 0.09 | Why? |
| Influenza A virus | 1 | 2020 | 2234 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.09 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.08 | Why? |
| Alcohol Drinking | 1 | 2019 | 1663 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.08 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.08 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.08 | Why? |
| Uncertainty | 1 | 2017 | 1888 | 0.08 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.07 | Why? |
| Laboratories | 1 | 2017 | 2858 | 0.07 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.06 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Travel | 2 | 2021 | 7220 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| Occupational Diseases | 1 | 2017 | 2787 | 0.06 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Infant | 5 | 2021 | 30274 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.05 | Why? |
| Child, Preschool | 5 | 2021 | 36283 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.04 | Why? |
| Empirical Research | 1 | 2017 | 72 | 0.04 | Why? |
| Humans | 19 | 2021 | 930598 | 0.04 | Why? |
| Compassionate Use Trials | 1 | 2021 | 632 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Africa South of the Sahara | 1 | 2021 | 1335 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Blood Culture | 1 | 2017 | 308 | 0.04 | Why? |
| Fluorescent Antibody Technique | 1 | 2017 | 835 | 0.03 | Why? |
| Occupational Health Services | 1 | 2017 | 219 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.03 | Why? |
| Ethanol | 1 | 2019 | 533 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Drug Utilization | 1 | 2017 | 619 | 0.03 | Why? |
| Adult | 8 | 2021 | 244371 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2018 | 1265 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Child | 4 | 2021 | 70012 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Aged | 6 | 2021 | 215776 | 0.02 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.02 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.02 | Why? |
| Female | 8 | 2021 | 380317 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Seasons | 1 | 2020 | 4071 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.02 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.02 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.02 | Why? |
| Viral Nonstructural Proteins | 1 | 2021 | 4810 | 0.02 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.01 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.01 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2017 | 29620 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.00 | Why? |